ClinicalTrials.Veeva

Menu

Shear Wave Elastography of Prostate Cancer (ElaProC)

U

University of Magdeburg

Status and phase

Completed
Phase 2

Conditions

Prostate Cancer

Treatments

Procedure: Transrectal random biopsy of the prostate
Device: Transrectal shear wave elastography of the prostate

Study type

Interventional

Funder types

Other

Identifiers

NCT02425163
MD-URO-0047

Details and patient eligibility

About

Evaluation of significant Shear Wave Elastography Parameters for Prostate Biopsy and Prostate Cancer detection.

Full description

This Study will evaluate the Shear Wave Elastography (SWE) Parameters for Prostate Biopsy and Prostate Cancer detection.

Enrollment

73 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspicious for prostate cancer with no pretreatment and Prostata specific Antigen (PSA) >4ng/ml or PSA velocity > 0.75 ng/ml per year or suspicious transrectal digital examination
  • Status after external beam radiotherapy of the prostate in localized prostate cancer and suspicious for local prostate cancer recurrence

Exclusion criteria

  • None.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

73 participants in 1 patient group

suspicious for Prostate Cancer
Active Comparator group
Description:
PSA \>4ng/ml or PSA-Velocity \>0.75ng/ml/a or suspicious rectal examination or Status after external beam therapy of the prostate in prostate cancer. Patients who are able for transrectal ultrasound examination. Transrectal shear wave elastography of the prostate for Transrectal random biopsy of the prostate.
Treatment:
Device: Transrectal shear wave elastography of the prostate
Procedure: Transrectal random biopsy of the prostate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems